feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / New Study: Gradual Tapering Cuts Relapse Risk

New Study: Gradual Tapering Cuts Relapse Risk

11 Dec, 2025

•

Summary

  • Slow tapering with psychological support significantly reduces relapse risk.
  • Abrupt or fast tapering of antidepressants carries the highest relapse risk.
  • Gradual withdrawal with support could prevent relapse in one in five individuals.
New Study: Gradual Tapering Cuts Relapse Risk

A groundbreaking study published in The Lancet Psychiatry reveals that the most effective strategy for discontinuing antidepressant medication involves a slow, gradual tapering of dosage alongside psychological support. This method was found to be nearly as effective as continuing the medication, significantly reducing the risk of depression relapse compared to abrupt cessation or rapid tapering, which carry the highest risks. Researchers analyzed data from over 17,300 patients across 76 clinical trials, concluding that updated clinical guidelines should promote individualized deprescribing with gradual tapering and structured psychological support to improve patient outcomes globally.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The most effective method involves a slow, gradual tapering of dosage combined with psychological support, as identified by a study in The Lancet Psychiatry.
Slow tapering, especially with psychological support, reduces the risk of depression relapse by 48% compared to abrupt stopping.
Abruptly stopping antidepressants or fast tapering without adequate support are associated with the highest risk of relapse.

Read more news on

Healthside-arrow
trending

Jerusalem daycare babies dead

trending

Severe geomagnetic storm alert

trending

Apple TV service disruption

trending

CFTC modernizes crypto regulations

trending

Punta Cana tourism surge

trending

Mets acquire Luis Robert Jr.

trending

Texas winter storm watch

trending

Milwaukee winter weather advisory

trending

Luka Doncic All-Star starter

You may also like

EEG Scans May Predict Antidepressant Sexual Issues

21 hours ago • 5 reads

article image

Risky Meds Still Given to Dementia Patients

13 Jan • 40 reads

article image

Exercise Beats Depression: New Study Finds

8 Jan • 54 reads

article image

Mind Matters: More Americans Focus on Mental Health

5 Jan • 77 reads

Antidepressant's Hidden Cost: Sex Life Suffers

15 Dec, 2025 • 162 reads

article image